CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ)

$11.6 -0.09 (-0.7699%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 79

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ) News Sources

Corvus Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary

13-03-2026

moby.co

Assessing Corvus Pharmaceuticals (CRVS) Valuation After Rapid Multi‑Year Share Price Gains

13-03-2026

yahoo.com

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting

21-04-2026

yahoo.com

Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors

23-04-2026

yahoo.com

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results

07-05-2026

yahoo.com

Return To Losses And New Shelf Offering Might Change The Case For Investing In Corvus Pharmaceuticals (CRVS)

10-05-2026

yahoo.com

Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting

14-05-2026

yahoo.com

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase

17-05-2026

fool.com

Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference

20-05-2026

yahoo.com

Adams Street Partners Exits Its 223,000-Share Paymentus (PAY) Position for $5.9 Million

24-05-2026

fool.com

CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ) Sentiment Trend

0 25 50 75 100 25 83 78 89 87 82 82 92 88 89 13-03-2026 21-04-2026 23-04-2026 07-05-2026 10-05-2026 14-05-2026 17-05-2026 20-05-2026 24-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ) FAQs

toggle

What is the current price of CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ)?

The current price of CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ) is $11.6.


toggle

CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ) absolute price change since previous trading day?

The absolute price change of CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ) since the previous trading day is $-0.09.


toggle

CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ) percentage price change since previous trading day?

The percentage price change of CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ) since the previous trading day is -0.7699%.


toggle

What is the most recent average sentiment score for CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ)?

The most recent average sentiment score for CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ) is 79 out of 100.


toggle

What is the most recent average sentiment for CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ)?

The most recent sentiment for CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ) is .


SEC-8K** Filing Available For CORVUS PHARMACEUTICALS INC (CRVS:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.